Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stetrix
Bartlett, Tennessee, United Stateslinkedin.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Stetrix has developed the Hem-Avert® Perianal Stabilizer, a non-invasive Class II medical device designed to prevent external hemorrhoids in women undergoing vaginal childbirth. The device is FDA approved for this indication. Retrospective clinical studies have evaluated its impact on reducing Cesarean section rates and shortening the second stage of labor; data may be used to support expanded labeling[5][6].
- Therapeutic areas
- Women's Health
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Therapeutic Medical Devices
02
Partnerships
No major pharmaceutical or biotech partnerships disclosed; some clinical collaborations with hospitals for evaluation studies[2][6]
Beyond the preview
Go deeper on Stetrix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Stetrix.